These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25919846)

  • 21. Psychopharmacology for Borderline Personality Disorder.
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):8-11. PubMed ID: 29596715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Datapoints: prescription patterns for mood and anxiety disorders in a community sample.
    Mojtabai R
    Psychiatr Serv; 1999 Dec; 50(12):1557. PubMed ID: 10577871
    [No Abstract]   [Full Text] [Related]  

  • 24. A systematic review and meta-analysis of digital interventions targeted at individuals with borderline personality disorder (BPD), emotionally unstable personality disorder (EUPD), and related symptoms.
    Drews-Windeck E; Greenwood K; Cavanagh K
    J Clin Psychol; 2023 Sep; 79(9):2155-2185. PubMed ID: 37185891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.
    Amad A; Thomas P; Perez-Rodriguez MM
    Curr Pharm Des; 2015; 21(23):3311-6. PubMed ID: 26088114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prescriptions of psychotropic drugs to children and adolescents in Germany].
    Franke C; Fegert JM; Krüger U; Kölch M
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):259-74. PubMed ID: 27058834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
    Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.
    Kolla NJ; Eisenberg H; Links PS
    Arch Suicide Res; 2008; 12(1):1-19. PubMed ID: 18240030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of medication in children with psychiatric disorders.
    Barton R
    Community Pract; 2007 Nov; 80(11):42, 44. PubMed ID: 18064853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are DSM-IV-TR borderline personality disorder, ICD-10 emotionally unstable personality disorder, and CCMD-III impulsive personality disorder analogous diagnostic categories across psychiatric nomenclatures?
    Lai CM; Leung F; You J; Cheung F
    J Pers Disord; 2012 Aug; 26(4):551-67. PubMed ID: 22867506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
    Timäus C; Meiser M; Bandelow B; Engel KR; Paschke AM; Wiltfang J; Wedekind D
    BMC Psychiatry; 2019 Dec; 19(1):393. PubMed ID: 31830934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PROPOSAL OF INITIAL PSYCHOTERAPEUTIC AND PSYCHOPHARMACOLOGICAL APPROACH IN PATIENTS WITH DIAGNOSE OF 5 DIFFERENT SUBTYPES OF BORDERLINE PERSONALITY DISORDER].
    Colombo MC; Hedderwick A; Tauguinas N; Rodante D
    Vertex; 2015; 26(119):17-27. PubMed ID: 26323109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of an integrated treatment for severe personality disorders. A 36-month pragmatic follow-up].
    Lana F; Sánchez-Gil C; Ferrer L; López-Patón N; Litvan L; Marcos S; Sierra AC; Soldevilla JM; Feixas G; Pérez V
    Rev Psiquiatr Salud Ment; 2015; 8(1):3-10. PubMed ID: 25432077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial impairment and treatment utilization by patients with borderline personality disorder, other personality disorders, mood and anxiety disorders, and a healthy comparison group.
    Ansell EB; Sanislow CA; McGlashan TH; Grilo CM
    Compr Psychiatry; 2007; 48(4):329-36. PubMed ID: 17560953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
    Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The process of managing medications in patients with borderline personality disorder.
    Silk KR
    J Psychiatr Pract; 2011 Sep; 17(5):311-9. PubMed ID: 21926526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.